Arda Therapeutics website screenshot

Arda Therapeutics

Arda Therapeutics is a San Carlos, California biotech company founded in 2021 that develops targeted cell depletion therapies for chronic disease. Rather than modulating the proteins that pathogenic cells produce, Arda uses a single-cell sequencing and computational discovery engine to map disease-specific cell states, identify surface markers on harmful cells, and design targeted biologics that selectively deplete them across fibrotic, autoimmune, and metabolic conditions. Backed by a $43M Series A led by a16z Bio + Health with GV, Two Sigma Ventures, Eli Lilly and others. This API Evangelist profile tracks the company's public developer and web surface; Arda currently publishes a corporate marketing site with no public developer API.

Arda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Depletion, and Single Cell.

Arda Therapeutics’ developer surface includes product news and 7 more developer resources.

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyTherapeuticsCell DepletionSingle CellDrug DiscoveryLife SciencesHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arda-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Arda Therapeutics Domain Security

TLSv1.3 · HSTS · DNSSEC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 6

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: arda-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arda-therapeutics.png
name: Arda Therapeutics
description: Arda Therapeutics is a San Carlos, California biotech company founded in 2021 that develops targeted cell depletion
  therapies for chronic disease. Rather than modulating the proteins that pathogenic cells produce, Arda uses a single-cell
  sequencing and computational discovery engine to map disease-specific cell states, identify surface markers on harmful cells,
  and design targeted biologics that selectively deplete them across fibrotic, autoimmune, and metabolic conditions. Backed
  by a $43M Series A led by a16z Bio + Health with GV, Two Sigma Ventures, Eli Lilly and others. This API Evangelist profile
  tracks the company's public developer and web surface; Arda currently publishes a corporate marketing site with no public
  developer API.
url: https://raw.githubusercontent.com/api-evangelist/arda-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- gv
x-tier: stub
x-tier-reason: portfolio-lead
x-headquarters: 1030 Brittan Ave, San Carlos, CA 94070
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Therapeutics
- Cell Depletion
- Single Cell
- Drug Discovery
- Life Sciences
- Healthcare
tags_raw:
- Company
- Biotechnology
- Therapeutics
- Cell Depletion
- Single-Cell
- Drug Discovery
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.ardatx.com/
- type: About
  url: https://www.ardatx.com/science
- type: Team
  url: https://www.ardatx.com/team
- type: News
  url: https://www.ardatx.com/news
- type: Careers
  url: https://www.ardatx.com/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/arda-therapeutics/
- type: Twitter
  url: https://twitter.com/Arda_Tx
- type: DomainSecurity
  url: security/arda-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence